X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (676) 676
female (416) 416
male (416) 416
index medicus (356) 356
neurofibromatosis 1 - physiopathology (277) 277
adult (256) 256
neurofibromatosis (248) 248
child (234) 234
adolescent (218) 218
clinical neurology (193) 193
middle aged (178) 178
neurofibromatosis 1 - complications (151) 151
children (148) 148
animals (129) 129
child, preschool (128) 128
magnetic resonance imaging (127) 127
neurosciences (125) 125
neurofibromatosis type 1 (106) 106
neurofibromatosis 2 - physiopathology (103) 103
neurofibromatosis 1 - genetics (94) 94
pediatrics (89) 89
genetics & heredity (85) 85
young adult (84) 84
treatment outcome (83) 83
neurofibromatosis 1 - diagnosis (82) 82
neurofibromatosis type-1 (78) 78
mice (77) 77
retrospective studies (77) 77
aged (76) 76
surgery (74) 74
nf1 (73) 73
follow-up studies (68) 68
mutation (68) 68
tumors (65) 65
neurofibromatosis 2 - complications (60) 60
neurofibromatosis 1 - pathology (58) 58
disease models, animal (56) 56
infant (56) 56
gene (55) 55
management (55) 55
neurology (53) 53
otorhinolaryngology (52) 52
neurofibromatosis 2 - genetics (49) 49
neuroma, acoustic - surgery (47) 47
congenital, hereditary, and neonatal diseases and abnormalities (46) 46
oncology (46) 46
medicine & public health (45) 45
vestibular schwannoma (44) 44
diagnosis (43) 43
neurofibromatosis type 2 (43) 43
neurofibromatosis 2 - surgery (42) 42
phenotype (42) 42
type-1 (41) 41
care and treatment (40) 40
neurofibromin 1 - genetics (39) 39
neuroma, acoustic - physiopathology (39) 39
mouse model (38) 38
neurofibromatosis 2 - pathology (38) 38
genetic aspects (35) 35
risk factors (35) 35
analysis (34) 34
brain (34) 34
research (34) 34
brain - physiopathology (33) 33
diagnosis, differential (33) 33
nervous system diseases (33) 33
recklinghausen's disease (32) 32
acoustic neuroma (31) 31
disease (31) 31
mutations (31) 31
neurofibromatosis 1 - metabolism (31) 31
neurofibromatosis 2 - diagnosis (31) 31
genetics (30) 30
neurofibromatosis 2 (30) 30
neurofibromatosis type-2 (30) 30
signal transduction (30) 30
tomography, x-ray computed (30) 30
disease progression (29) 29
neuroma, acoustic - pathology (29) 29
health aspects (27) 27
neurofibromatosis 1 (27) 27
ophthalmology (27) 27
vonrecklinghausen neurofibromatosis (27) 27
brain - pathology (26) 26
expression (26) 26
nf2 (26) 26
radiography (26) 26
cell biology (25) 25
neoplasms (25) 25
time factors (25) 25
case-control studies (24) 24
gliomas (24) 24
hearing (24) 24
nf1 gene (24) 24
prognosis (24) 24
ras (24) 24
brain neoplasms - physiopathology (23) 23
cells, cultured (23) 23
disorders (23) 23
neurilemmoma - physiopathology (23) 23
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (700) 700
French (12) 12
German (4) 4
Spanish (3) 3
Chinese (2) 2
Japanese (2) 2
Croatian (1) 1
Hebrew (1) 1
Hungarian (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Genes & development, ISSN 0890-9369, 2010, Volume 24, Issue 16, pp. 1718 - 1730
.... We report here that liver-specific deletion of the neurofibromatosis type 2 (Nf2) tumor suppressor gene in the developing or adult mouse specifically yields a dramatic... 
Liver progenitor | Hepatocellular carcinoma | Cholangiocellular carcinoma | NF2 | EGFR | Merlin | RAT | MEDIATES CONTACT INHIBITION | C-MYC | STEM-CELL NICHE | DEVELOPMENTAL BIOLOGY | CELL BIOLOGY | cholangiocellular carcinoma | ORGAN SIZE | HEPATOCELLULAR-CARCINOMA | NF2 TUMOR-SUPPRESSOR | liver progenitor | GROWTH-FACTOR-ALPHA | MOUSE MODEL | GENETICS & HEREDITY | OVAL CELLS | hepatocellular carcinoma | Neurofibromin 2 - genetics | Cell Proliferation | Male | Stem Cells - cytology | Liver - physiopathology | Phosphoproteins - metabolism | Stem Cells - metabolism | Receptor, Epidermal Growth Factor - metabolism | Carcinoma, Hepatocellular - genetics | Liver Neoplasms - physiopathology | Female | Neurofibromin 2 - metabolism | Carcinoma, Hepatocellular - physiopathology | Cholangiocarcinoma - physiopathology | Liver Neoplasms - genetics | Signal Transduction | Cells, Cultured | Hepatomegaly - genetics | Neurofibromatosis 2 - genetics | Animals | Homeostasis - physiology | Cholangiocarcinoma - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Liver - cytology | Mice | Adaptor Proteins, Signal Transducing - metabolism | Hepatomegaly - physiopathology | Homeostasis - genetics | Physiological aspects | Tumor suppressor genes | Genetic aspects | Hepatoma | Research | Stem cells | Research Paper
Journal Article
Journal of neuro-oncology, ISSN 1573-7373, 2015, Volume 122, Issue 2, pp. 313 - 320
Neurofibromatosis type 2 (NF2) is a genetic disorder with bilateral vestibular schwannomas (VS... 
Neurofibromatosis 2 | Meningioma | Tumor stabilization | Time to tumor progression | Vestibular schwannoma | ACTIVATION | BEVACIZUMAB | RADIOGRAPHIC REGRESSION | NATURAL-HISTORY | HEARING | TUMOR-CONTROL | CLINICAL NEUROLOGY | TUBEROUS SCLEROSIS COMPLEX | STEREOTACTIC RADIOSURGERY | ONCOLOGY | GROWTH | Neurofibromatosis 2 - drug therapy | Prospective Studies | Vestibulocochlear Nerve Diseases - physiopathology | Follow-Up Studies | TOR Serine-Threonine Kinases - metabolism | Humans | Cranial Nerve Neoplasms - drug therapy | Male | Antineoplastic Agents - therapeutic use | Mechanistic Target of Rapamycin Complex 1 | Multiprotein Complexes - antagonists & inhibitors | TOR Serine-Threonine Kinases - antagonists & inhibitors | Young Adult | Multiprotein Complexes - metabolism | Antineoplastic Agents - adverse effects | Cranial Nerve Neoplasms - physiopathology | Neurofibromatosis 2 - physiopathology | Everolimus - adverse effects | Biomarkers, Tumor - metabolism | Adult | Everolimus - therapeutic use | Female | Vestibulocochlear Nerve Diseases - drug therapy | Treatment Outcome | Tumor Burden | Disease Progression | Neurilemmoma - pathology | Neurilemmoma - physiopathology | Neurofibromatosis 2 - pathology | Disease-Free Survival | Vestibulocochlear Nerve Diseases - pathology | Cranial Nerve Neoplasms - pathology | Neurilemmoma - drug therapy | Adolescent | Medicine, Experimental | Medical research | Neurofibromatosis
Journal Article
Nature protocols, ISSN 1750-2799, 2019, Volume 14, Issue 2, pp. 541 - 555
Journal Article
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 11/2019, Volume 31, Issue 6, pp. 562 - 567
PURPOSE OF REVIEWNeurofibromatosis type 2 (NF2) is a schwannoma predisposition syndrome, alongside schwannomatosis related to germline LZTR1 and SMARCB1 pathogenic variants... 
SMARCB1 | ONCOLOGY | SCHWANNOMA | MUTATION | neurofibromatosis type 2 | schwannomatosis | LZTR1 | DIAGNOSTIC-CRITERIA | CHILDREN | Neurofibromatosis 2 - pathology | Animals | Neurofibromatosis 2 - genetics | Humans | Neurofibromatosis 2 - physiopathology
Journal Article
Journal Article
Journal of Neurology, ISSN 0340-5354, 1/2013, Volume 260, Issue 1, pp. 38 - 46
Journal Article
Free radical biology & medicine, ISSN 0891-5849, 2016, Volume 97, pp. 212 - 222
Journal Article